{"id":266,"date":"2009-03-18T09:53:21","date_gmt":"2009-03-18T00:53:21","guid":{"rendered":"http:\/\/cfonews.main.jp\/cfonews\/?p=266"},"modified":"2023-07-07T11:50:53","modified_gmt":"2023-07-07T02:50:53","slug":"%e3%82%a2%e3%82%b9%e3%83%86%e3%83%a9%e3%82%b9%e3%80%81%e7%b1%b3%e3%83%90%e3%82%a4%e3%82%aa%e3%83%99%e3%83%b3%e3%83%81%e3%83%a3%e3%83%bc%e8%b2%b7%e5%8f%8e%e6%96%ad%e5%bf%b5","status":"publish","type":"post","link":"https:\/\/www.cfonews.jp\/?p=266","title":{"rendered":"\u30a2\u30b9\u30c6\u30e9\u30b9\u3001\u7c73\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u8cb7\u53ce\u65ad\u5ff5"},"content":{"rendered":"<h3><span style=\"color: #ff6600;\">\u30a2\u30b9\u30c6\u30e9\u30b9\u3001\u7c73\u793e\u8cb7\u53ce\u3092\u65ad\u5ff5\u3000\u540c\u696d\u306e\u5408\u610f\u984d\u3092\u4e0a\u56de\u308c\u305a<\/span><\/h3>\n<blockquote><p><span style=\"color: #003366;\"><strong>\u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u306f16\u65e5\u3001\u7c73\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u3001\uff23\uff36\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\uff08\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\uff09\u306e\u8cb7\u53ce\u3092\u65ad\u5ff5\u3057\u305f\u3068\u767a\u8868\u3057\u305f\u3002\u4eca\u670826\u65e5\u3092\u671f\u65e5\u306b\uff23\uff36\u682a\u5f0f\u306e\u516c\u958b\u8cb7\u3044\u4ed8\u3051\uff08\uff34\uff2f\uff22\uff09\u3092\u5b9f\u65bd\u3057\u3066\u3044\u305f\u304c\u3001\u540c12\u65e5\u306b\u7c73\u88fd\u85ac\u4f1a\u793e\u304c\u30a2\u30b9\u30c6\u30e9\u30b9\u306e\u8cb7\u3044\u4ed8\u3051\u4fa1\u683c\uff081\u682a16\u30c9\u30eb\uff09\u3092\u4e0a\u56de\u308b\u540c20\u30c9\u30eb\u3067\uff23\uff36\u3092\u8cb7\u53ce\u3059\u308b\u3053\u3068\u3067\uff23\uff36\u53d6\u7de0\u5f79\u4f1a\u3068\u5408\u610f\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\uff34\uff2f\uff22\u3092\u53d6\u308a\u4e0b\u3052\u308b\u3002<\/strong><br \/>\n\uff08<a href=\"http:\/\/www.nikkei.co.jp\/news\/past\/honbun.cfm?i=AT1D1607Y%2016032009&amp;g=S1&amp;d=20090316\">NIKKEI NET 2009\u5e743\u670818\u65e5<\/a>\uff09<\/span><\/p><\/blockquote>\n<h3>\u3010CFO\u306a\u3089\u3053\u3046\u8aad\u3080\u3011<\/h3>\n<p>\u7c73\u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u306f\u3001\uff12\u6708\uff12\uff17\u65e5\u306b\u7c73\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u3001CV Therapeutics\u682a\u5f0f\u306e\u6575\u5bfe\u7684TOB\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u304c\u3001CV\u53d6\u7de0\u5f79\u4f1a\u306f\u8cb7\u53ce\u4fa1\u683c\u304c\u5b89\u3044\u3053\u3068\u3092\u7406\u7531\u306b\u3001\u30a2\u30b9\u30c6\u30e9\u30b9\u304c\u6628\u5e74\u672b\u884c\u3063\u305f\u8cb7\u53ce\u63d0\u6848\u3092\u62d2\u5426\u3057\u3066\u3044\u307e\u3057\u305f\u3002<\/p>\n<p>Gilead Sciences, Inc.\u304c\u3001\uff13\u6708\uff11\uff12\u65e5\u306b\u3001\u30a2\u30b9\u30c6\u30e9\u30b9\u306eTOB\u4fa1\u683c16\u30c9\u30eb\u3092\u4e0a\u56de\u308b\u30011\u682a\u3042\u305f\u308a20\u30c9\u30eb\u306e\u73fe\u91d1\u3092\u5bfe\u4fa1\u3068\u3057\u3066\u540c\u793e\u3092\u8cb7\u53ce\u3059\u308b\u3053\u3068\u306b\u5408\u610f\u3057\u305f\u65e8\u516c\u8868\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<p>\u30a2\u30b9\u30c6\u30e9\u30b9\u304cTOB\u4fa1\u683c\u3092\u5f15\u304d\u4e0a\u3052\u308b\u304b\u3069\u3046\u304b\u5bfe\u5fdc\u304c\u6ce8\u76ee\u3055\u308c\u307e\u3057\u305f\u304c\u3001<span style=\"color: #008000;\">\u300cCV Therapeutics\u793e\u3088\u308a\u516c\u8868\u3055\u308c\u305fGilead Sciences, Inc.\u306b\u3088\u308b\u8cb7\u53ce\u4fa1\u683c\u306e\u6c34\u6e96\u306f\u5f53\u793e\u306e\u682a\u4e3b\u4fa1\u5024\u306e\u5411\u4e0a\u306b\u898b\u5408\u308f\u306a\u3044\u3082\u306e\u3068\u5224\u65ad\u3057\u3001\u3053\u306e\u305f\u3073CV Therapeutics\u793e\u8cb7\u53ce\u63d0\u6848\u306e\u7d42\u7d50\u3092\u6c7a\u5b9a\u300d\uff0820090316\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\uff09<\/span>\u3092\u6c7a\u65ad\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u30a2\u30b9\u30c6\u30e9\u30b9\u306e\u682a\u4fa1\u306f\u3001\uff13\u6708\uff11\uff12\u65e5\u306e\u516c\u8868\u3092\u53d7\u3051\u4e0a\u6607\u3001\u7d50\u679c\u3068\u3057\u3066\u3001\u5e02\u5834\u3082\u30a2\u30b9\u30c6\u30e9\u30b9\u306e\u8cb7\u53ce\u65ad\u5ff5\u3092\u5f8c\u62bc\u3057\u3057\u305f\u5f62\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-267\" title=\"20090318\" src=\"https:\/\/cfonews.main.jp\/cfonews\/wp-content\/uploads\/2009\/03\/20090318.gif\" alt=\"20090318\" width=\"512\" height=\"301\" \/><\/p>\n<h3>\u3010\u30ea\u30f3\u30af\u3011<\/h3>\n<p style=\"padding-left: 30px;\"><a href=\"http:\/\/www.astellas.com\/jp\/corporate\/news\/detail\/cv-therapeutics-4.html \">2009\u5e743\u670816\u65e5\u300c\u7c73\u56fd\u533b\u85ac\u54c1\u4f1a\u793eCV Therapeutics\u793e\u306b\u5bfe\u3059\u308b\u8cb7\u53ce\u63d0\u6848\u7d42\u7d50\u306b\u95a2\u3059\u308b\u304a\u77e5\u3089\u305b\u300d\u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u30a2\u30b9\u30c6\u30e9\u30b9\u3001\u7c73\u793e\u8cb7\u53ce\u3092\u65ad\u5ff5\u3000\u540c\u696d\u306e\u5408\u610f\u984d\u3092\u4e0a\u56de\u308c\u305a \u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u306f16\u65e5\u3001\u7c73\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u3001\uff23\uff36\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\uff08\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\uff09\u306e\u8cb7\u53ce\u3092\u65ad\u5ff5\u3057\u305f\u3068\u767a\u8868\u3057\u305f\u3002\u4eca\u670826\u65e5\u3092\u671f\u65e5\u306b\uff23\uff36\u682a\u5f0f\u306e\u516c\u958b\u8cb7\u3044\u4ed8\u3051\uff08\uff34\uff2f\uff22\uff09\u3092\u5b9f [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"swell_btn_cv_data":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[8],"tags":[126,151],"class_list":["post-266","post","type-post","status-publish","format-standard","hentry","category-ma","tag-ma","tag-151"],"_links":{"self":[{"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=\/wp\/v2\/posts\/266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=266"}],"version-history":[{"count":1,"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=\/wp\/v2\/posts\/266\/revisions"}],"predecessor-version":[{"id":7434,"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=\/wp\/v2\/posts\/266\/revisions\/7434"}],"wp:attachment":[{"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cfonews.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}